Research Desk › Research library › CJC-1295

Hormone signaling · RESEARCH FILE

CJC-1295: what the research says

Last reviewed 2026-11-09 · Written from the published papers linked below

THE SIMPLE ANSWER

No fancy words

A small human study found that CJC-1295 changed certain hormone levels. That does not mean it has been proven to improve health or performance.

What kind of science?

Small human trials

Studies in people

Hormone levels measured

What we know

Broader benefits not proven

Important: Research on a compound is not proof that it is safe or effective for human use.

What is it?

A small human study found that CJC-1295 changed certain hormone levels. That does not mean it has been proven to improve health or performance.

Why are scientists studying it?

Research area: Hormone signaling. Studies focus on growth hormone signaling research.

What have they found?

A 2006 randomized study measured growth-hormone and IGF-1 changes in healthy adults. The study did not establish broad, long-term human benefits or safety.

What kind of studies exist?

2006 · Randomized controlled studies: Researchers measured hormone responses in healthy adults, not long-term treatment outcomes.
2026 · Review: Overview of research gaps involving several investigational peptides.

What don't we know?

Broader benefits not proven. Hormone levels measured. A result in cells or animals does not prove the same thing happens in people, and one small study cannot settle a question.

Quick answers

What is CJC-1295?

A small human study found that CJC-1295 changed certain hormone levels. That does not mean it has been proven to improve health or performance.

Has CJC-1295 been proven to work in people?

Broader benefits not proven. Hormone levels measured.

What kind of research exists on CJC-1295?

Small human trials. A 2006 randomized study measured growth-hormone and IGF-1 changes in healthy adults. The study did not establish broad, long-term human benefits or safety.

Where can I read the original CJC-1295 research?

Every study on this page links to its original record on PubMed. The newest papers are also searchable live on the Research Desk home page.

Read the actual research

2006 · Randomized controlled studies

Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults

Researchers measured hormone responses in healthy adults, not long-term treatment outcomes.

Read original source ↗

2026 · Review

Injectable Peptide Therapy: A Primer for Orthopaedic and Sports Medicine Physicians

Overview of research gaps involving several investigational peptides.

Read original source ↗

See the newest CJC-1295 papers live from the research libraries → · Trial registry ↗

GO STRAIGHT TO THE SOURCE

Trusted research libraries

PubMed ↗Original medical and life-science publication records.Europe PMC ↗Scientific papers and many open-access full texts.ClinicalTrials.gov ↗Public register of human studies; registration ≠ proof.FDA drug information ↗U.S. regulatory and approval information.

UNDERSTAND THE EVIDENCE

Which study matters most?

Cells in a dishAn early clue. Not proof in people.

Animal studyUseful science. Animals are not people.

Human studyLooks at people. Design and size matter.

Strong comparison trialUsually stronger evidence when done well.

SEPARATE RESEARCH MARKETPLACE

Need laboratory research supplies?

IntellMeds is a separate account-based store for qualified research buyers. Products are labeled for research use only, not human use.

Visit IntellMeds.net ↗

Independent research summaries are educational. They are not medical advice, treatment guidance, or proof that any investigational compound is safe or effective.